DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)
South Korea
· Delayed Price · Currency is KRW 5,380.00
+170.00 (3.26%)
At close: Mar 6, 2026
DongKoo Bio & Pharma Revenue
DongKoo Bio & Pharma had revenue of 62.02B KRW in the quarter ending September 30, 2025, a decrease of -6.29%. This brings the company's revenue in the last twelve months to 238.39B, down -6.04% year-over-year. In the year 2024, DongKoo Bio & Pharma had annual revenue of 249.27B with 15.57% growth.
Revenue (ttm)
238.39B
Revenue Growth
-6.04%
P/S Ratio
0.58
Revenue / Employee
590.07M
Employees
404
Market Cap
138.19B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KOREA PHARMA | 90.11B |
| PHARMARESEARCH BIO | 178.19M |
| Kyung Dong Pharmaceutical | 193.64B |
| HYUNDAI BIOLAND | 129.68B |
| High Tech Pharm | 75.60B |
| GREEN CROSS WellBeing | 151.06B |
| Organoidsciences | 2.55B |
| Samik Pharmaceutical Company LTD. | 58.88B |